|
1
|
McGuire S: World Cancer Report 2014.
Geneva, Switzerland: World Health Organization, International
Agency for Research on Cancer, WHO Press, 2015. Adv Nutr.
7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaatsch P: Epidemiology of childhood
cancer. Cancer Treat Rev. 36:277–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lim S, Sala C, Yoon J, Park S, Kuroda S,
Sheng M and Kim E: Sharpin, a novel postsynaptic density protein
that directly interacts with the shank family of proteins. Mol Cell
Neurosci. 17:385–397. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hogenesch H, Gijbels MJ, Offerman E, van
Hooft J, van Bekkum DW and Zurcher C: A spontaneous mutation
characterized by chronic proliferative dermatitis in C57BL mice. Am
J Pathol. 143:972–982. 1993.PubMed/NCBI
|
|
5
|
Seymour RE, Hasham MG, Cox GA, Shultz LD,
Hogenesch H, Roopenian DC and Sundberg JP: Spontaneous mutations in
the mouse Sharpin gene result in multiorgan inflammation, immune
system dysregulation and dermatitis. Genes Immun. 8:416–421. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jung J, Kim JM, Park B, Cheon Y, Lee B,
Choo SH, Koh SS and Lee S: Newly identified tumor-associated role
of human Sharpin. Mol Cell Biochem. 340:161–167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bollag G, Hirth P, Tsai J, Zhang J,
Ibrahim PN, Cho H, Spevak W, Zhang C, Zhang Y, Habets G, et al:
Clinical efficacy of a RAF inhibitor needs broad target blockade in
BRAF-mutant melanoma. Nature. 467:596–599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bii VM, Rae DT and Trobridge GD: A novel
gammaretroviral shuttle vector insertional mutagenesis screen
identifies SHARPIN as a breast cancer metastasis gene and
prognostic biomarker. Oncotarget. 6:39507–39520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De Melo J and Tang D: Elevation of SIPL1
(SHARPIN) increases breast cancer risk. PLoS One. 10:e01275462015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sieber S, Lange N, Kollmorgen G, Erhardt
A, Quaas A, Gontarewicz A, Sass G, Tiegs G and Kreienkamp HJ:
Sharpin contributes to TNFα dependent NFκB activation and
anti-apoptotic signalling in hepatocytes. PLoS One. 7:e299932012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gerlach B, Cordier SM, Schmukle AC,
Emmerich CH, Rieser E, Haas TL, Webb AI, Rickard JA, Anderton H,
Wong WW, et al: Linear ubiquitination prevents inflammation and
regulates immune signalling. Nature. 471:591–596. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tomonaga M, Hashimoto N, Tokunaga F,
Onishi M, Myoui A, Yoshikawa H and Iwai K: Activation of nuclear
factor-kappa B by linear ubiquitin chain assembly complex
contributes to lung metastasis of osteosarcoma cells. Int J Oncol.
40:409–417. 2012.PubMed/NCBI
|
|
13
|
Liang Y and Sundberg JP: SHARPIN regulates
mitochondria-dependent apoptosis in keratinocytes. J Dermatol Sci.
63:148–153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He L, Ingram A, Rybak AP and Tang D:
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN
inhibition in human tumor cells. J Clin Invest. 120:2094–2108.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi Y, Paluch BE, Wang X and Jiang X: PTEN
at a glance. J Cell Sci. 125:4687–4692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kwon RJ, Han ME, Kim JY, Liu L, Kim YH,
Jung JS and Oh SO: ZHX1 promotes the proliferation, migration and
invasion of cholangiocarcinoma cells. PLoS One. 11:e01655162016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma X, Huang M, Wang Z, Liu B, Zhu Z and Li
C: ZHX1 inhibits gastric cancer cell growth through inducing
cell-cycle arrest and apoptosis. J Cancer. 7:60–68. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Potter CS, Sundberg JP and
Hogenesch H: SHARPIN is a key regulator of immune and inflammatory
responses. J Cell Mol Med. 16:2271–2279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tokunaga F, Nakagawa T, Nakahara M, Saeki
Y, Taniguchi M, Sakata S, Tanaka K, Nakano H and Iwai K: SHARPIN is
a component of the NF-κB-activating linear ubiquitin chain assembly
complex. Nature. 471:633–636. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rantala JK, Pouwels J, Pellinen T, Veltel
S, Laasola P, Mattila E, Potter CS, Duffy T, Sundberg JP,
Kallioniemi O, et al: SHARPIN is an endogenous inhibitor of
β1-integrin activation. Nat Cell Biol. 13:1315–1324. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Landgraf K, Bollig F, Trowe MO, Besenbeck
B, Ebert C, Kruspe D, Kispert A, Hänel F and Englert C: Sipl1 and
Rbck1 are novel Eya1-binding proteins with a role in craniofacial
development. Mol Cell Biol. 30:5764–5775. 2010. View Article : Google Scholar : PubMed/NCBI
|
